WHO Drug Information
Volume 21, Number 4, 2007
This final issue of WHO DRUG INFORMATION for 2007 highlights the 30 year anniversary of WHO's Essential Medicines concept and the Model List of Essential Medicines.
Feature articles include a review of estrogen and parkinsonism using the WHO adverse reactions database. Two perspectives on generic substitution of medicines are provided from Jamaica and Canada.
An overview is provided of latest developments in quality guidance from the International Conference on Harmonization (ICH). In addition, International Pharmacopoeia monographs for oxytocin are proposed for comment.
The section on Safety and Efficacy gives the latest information on signals and reports of adverse drug reactions, with other news from around the world, including labeling changes. This is complemented by Regulatory Action and News which provides the most recent developments from regulatory authorities, and particularly those having an impact on decision-taking.
Several informational documents and events are reviewed and the journal concludes with Proposed list number 98 of International Nonproprietary Names (INN).